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Abstract 
 
Our aim was to investigate the effect of Withaferin-A on bone marrow micronucleus frequency and 
buccal mucosa detoxication agents during 7, 12–dimethylbenz[a]anthracene (DMBA) induced hamster buccal 
pouch carcinogenesis. Oral squamous cell carcinoma was developed in hamsters’ buccal pouches by painting 
0.5% DMBA in liquid paraffin, three times per week for 14 weeks. We observed 100% tumor formation in 
DMBA painted hamsters. Elevated frequency of bone marrow micronucleated polychromatic erythrocytes 
(MnPCEs) and decrease in buccal mucosa phase II detoxication agents were noticed in tumor bearing hamsters. 
Oral administration of Withaferin-A significantly reduced the micronucleus frequency and brought back the 
status of phase II detoxication agents in DMBA painted hamsters. Our study thus demonstrated the protective 
effect of Withaferin-A on DMBA-induced micronucleus frequency in the bone marrow of golden Syrian 
hamsters. Also, Withaferin-A maintained the status of buccal mucosa detoxication agents during DMBA-induced 
hamster buccal pouch carcinogenesis.  
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Abbreviations:  
DMBA - 7,12–dimethylbenz[a]anthracene;  
MnPCEs - micronucleated polychromatic erythrocytes;  
PCEs - polychromatic erythrocytes; 
 NCEs - Normochromatic erythrocytes; 
 GST - Glutathione-S-transferase;  
GSSG – Oxidized glutathione; GSH-reduced glutathione. 
 
 
 
Introduction 
 
 Cancer of the oral cavity results due to repeated exposure of carcinogens to the entire epithelial cells of 
the oral cavity. 7, 12–dimethylbenz[a]anthracene (DMBA) is the most widely used organ specific carcinogen to 
induce oral carcinogenesis in the buccal pouches of golden Syrian hamster. The pre-cancerous and cancerous 
lesions induced by this potent carcinogen are morphologically, histologically and biochemically similar to that of 
human oral carcinoma. Also, DMBA induced oral cancer expresses similar molecular changes that are expressed 
in human oral carcinoma (Miyata et al., 2001; Hodgson, 2000; Senthil et al., 2007). 
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 Cytogenetic markers such as micronuclei frequency are relatively rapid, facile and sensitive indicators of 
genetic damage. Micronuclei could be formed from either lagging anaphase chromosome or anaphase bridges 
that can be detected in the cytoplasm of a daughter cell after cell division (Morita et al., 1997). Bone marrow 
micronucleus test has been widely used as a tool to indicate carcinogen-induced DNA damage as well as to assess 
the antigenotoxic effect of natural and synthetic chemopreventive agents (Miyamoto et al., 2007). Several studies 
have reported that phytochemicals inhibit neoplastic transformation by inducing phase II defoliation agents. 
Glutathione-S-Transferase (GST) detoxifies carcinogens either by destroying their reactive centers or facilitating 
their excretion by conjugation process (Dasgupta et al., 2004).  
Withania somnifera (Solanaceae), a shrub commonly found on the Indian subcontinent, has been used 
for centuries as a traditional medicine for various human ailments. Experimental studies have reported that W. 
somnifera have antitumor and immunomodulatory activities (Davis and Kuttan, 2000, Davis and Kuttan, 2001). 
Withaferin-A, a highly oxygenated steroidal lactone, is the principal withanolide in Indian W. somnifera and its 
related Solanaceae species. Diverse pharmacological activities reported for Withaferin-A includes anti-
inflammatory, antitumor and antioxidant properties (Sharada et al., 1996; Bhattacharya et al., 1997). The 
chemical structure of Withaferin-A is given in Figure 1.  
To the best of our knowledge, we have found no scientific literature on modifying effects of Withaferin-
A on bone marrow micronucleus frequency and buccal mucosa detoxicating agents during DMBA induced 
hamster buccal pouch carcinogenesis. The present study was thus designed to assess the protective role of 
Withaferin-A on bone marrow micronucleus frequency and buccal mucosa detoxicating agents during DMBA 
induced hamster buccal pouch carcinogenesis. 
 
 
 
Materials and Methods 
Animals 
Male golden Syrian hamsters, 8-10 weeks old weighing 80-120g, were purchased from National Institute 
of Nutrition, Hyderabad, India, and maintained in Central Animal House, Rajah Muthiah Medical College and 
Hospital, Annamalai University. The hamsters were housed four or five in a polypropylene cage and provided 
standard pellet diet and water ad libitum. The hamsters were maintained under controlled conditions of 
temperature and humidity with a 12h light/dark cycle.  The hamsters were maintained as per the principles and 
guidelines of the ethical committee for animal care of Annamalai University in accordance with Indian National 
Law on animal care and use. The experimental design was approved by the Annamalai University animal ethical 
committee [Reg. No: 160/1999/CPCSEA], Annamalai University, Annamalainagar, India. 
 
Chemicals 
 
 7,12-dimethylbenz[a]anthracene (DMBA), Colchicine, Giemsa and May-Grunwald’s stain were 
purchased from Sigma-Aldrich Chemical Pvt. Ltd., Bangalore, India and all other reagents used were of 
analytical grade.  
 
Isolation of Withaferin-A from Withania somnifera root 
 
Withaferin-A (WA) was extracted and isolated from commercially available Withania somnifera root 
powder by the method of Subramanian and Sethi (1969). The crude extract was prepared with 95% ethanol and 
further fractionation was carried out using petroleum ether, ether and chloroform, in that order. The ether and 
chloroform fractions were subjected to column chromatography (neutral alumina) and thin layer chromatography 
(silica gel). The final product, Wihaferin-A, a steroidal lactone (4β, 27 dihydroxy-1-oxo-5β, 6β, epoxy witha 2-24 
dienolide) was obtained as a creamy white crystalline substance, which has Rf = 0.4 and molecular weight 470. 
The identity of the isolated Withaferin-A was done by Mass spectral analysis and its identity was confirmed by 
comparing with the authentic Withaferin-A, purchased from Calbiochem, Darmstadt, Germany. The yield and 
purity of the isolated Withaferin-A was found to be 0.11% and >90% respectively. For experimental studies, the 
obtained Withaferin-A was first dissolved in a few drops of absolute ethanol followed by dilution with 30% 
polyethylene glycol-400 (PEG-400) in phosphate-buffered saline (PBS). 
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Figure 1: Chemical structure of Withaferin-A 
 
 
 
Experimental design  
 
A total number of 40 hamsters were randomized into four groups of 10 hamsters each. Group 1 hamsters 
were served as control and were painted with liquid paraffin thrice a week for 14 weeks on their left buccal 
pouches. Groups 2 and 3 hamsters were painted with 0.5% DMBA in liquid paraffin thrice a week for 14 weeks 
on their left buccal pouches. DMBA painting in hamsters’ buccal pouches was done using number 4 painting 
brush, which leaves approximately 0.4mg DMBA for each application (Shklar, 1999). Group 2 hamsters received 
no other treatment. Group 3 hamsters were orally given Withaferin-A at a dose of 20mg/kg bw, starting one week 
before the exposure to the carcinogen and continued on days alternate to DMBA painting, until the hamsters were 
sacrificed. Group 4 hamsters received oral administration of Withaferin-A alone throughout the experimental 
period. The experiment was terminated at the end of 14 weeks and all hamsters were sacrificed by cervical 
dislocation.  
The numbers of tumors in the hamsters’ buccal pouches were counted. The diameter of each tumor was 
measured with a caliper. The tumor volume was calculated by the formula, 
 
   volume (v) = 4/3 pi           
 
 where, D1, D2 and D3 are the three diameters (mm) of the tumor. Tumor burden was calculated by multiplying 
tumor volume and the number of tumors/hamster. 
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Bone marrow micronucleus test 
 
Bone marrow micronucleus test was carried out according to the method of Schmid (1975). The femur 
bones removed from the hamsters were cleaned and the content was flushed into tube containing 1 ml of calf 
serum and was centrifuged at 500 g for 10 mins. The pellet obtained was suspended with few drops of fresh 
serum and slides were prepared and air-dried for 18 hours. After drying, the slides were stained with May 
Grunwald stain followed by Giemsa stain. The frequency of MnPCEs in each group was calculated by scoring 
2500 polychromatic erythrocytes (PCEs) per hamster. 
 
 
Biochemical estimations 
 
Biochemical studies were conducted on buccal mucosa of control and experimental hamsters in each 
group. Tissue samples from hamsters were washed with ice cold saline and homogenized using appropriate buffer 
[Glutathione-S-Transferase (GST) – 0.3 M phosphate buffer, PH 6.5; GSH – 0.4 M phosphate buffer, pH – 7.0] 
in an all glass homogenizer with teflon pestle and used for biochemical estimations.  
The reduced glutathione level in the buccal mucosa was determined by the method of Beutler and Kelley 
(1963). The technique involves protein precipitation by meta-phosphoric acid and spectrophotometric assay at 
412nm of the yellow derivative obtained by the reaction of the supernatant with 5-5’dithiobis-2-nitrobenzoic acid. 
The activity of glutathione-S-transferase (GST) in buccal mucosa tissue homogenate was assayed by the method 
of Habig et al (1994). GST activity was measured by incubating the tissue homogenate with the substrate 1-
chloro 2,4 dinitrobenzene (CDNB). The absorbance was followed for 5 mins at 540nm after the reaction was 
started by the addition of reduced glutathione. The level of oxidized glutathione (GSSG) was estimated by the 
method of Anderson (1985). This method is based on oxidation of reduced nicotinamide adenine dinucleotide 
phosphate by glutathione, which was read at 340nm. 
 
Statistical Analysis  
 
 The data are expressed as mean ± SD. Statistical comparisons were performed by one way analysis of 
variance (ANOVA), followed by Duncan’s Multiple Range Test (DMRT). The results were considered 
statistically significant if the p values were 0.05 or less. 
 
 
 
 
 
Results  
  
Table 1 shows the tumor incidence, tumor volume and tumor burden of control and experimental 
hamsters in each group. We have observed 100% tumor formation with mean tumor volume (384.10 mm³) and 
tumor burden (1344.35 mm³) in DMBA alone painted hamsters (Group 2). Oral administration of Withaferin-A at 
a dose of 20mg/kg bw for 14 weeks completely prevented the tumor incidence, tumor volume and tumor burden 
in DMBA painted hamsters (Group 3). No tumors were observed in control hamsters painted with liquid paraffin 
alone (Group 1) as well as Withaferin-A alone administered hamsters (Group 4). 
The frequency of MnPCEs in control and experimental hamsters in each group are given in Table 2. 
Hamsters painted with DMBA alone (group 2) for 14 weeks showed higher frequency of MnPCEs as compared 
to control hamsters. The frequencies of MnPCEs were significantly reduced in DMBA painted hamsters treated 
with Withaferin-A Orally (group 3) for 14 weeks. Oral administration of Withaferin-A alone (group 4) to 
hamsters displayed no significant differences in MnPCEs as compared to control hamsters (group 1)  
Table 3 shows the status of GSH, GSSG and GST in the buccal mucosa of control and experimental 
hamsters in each group. The status of GSH and GST were significantly increased whereas GSSG was decreased 
in tumor bearing hamsters (Group 2) as compared to control hamsters. Oral administration of Withaferin-A to 
DMBA painted hamsters (Group 3) significantly reverted to near normal concentrations. Hamsters painted with 
Withaferin-A alone (Group 4) showed no significant difference in the status of GSH, GSSG and GST as 
compared to control hamsters (Group 1). 
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Table 1. Incidence of oral neoplasms in control and experimental hamsters in each group (n = 10) 
 
Groups 
---------------------   
Parameters 
 
Group 1  
Control 
Group 2  
DMBA 
Group 3 
DMBA + 
Withaferin-A 
Group 4  
Withaferin-A 
alone 
Tumor incidence 
(Squamous cell 
carcinoma)  
0 100% 0 0 
Total number of 
tumors 0 35(10) 0 0 
Tumor volume 
(mm3) 0 384.1 (10) 0 0 
Tumor burden (mm3) 0 1344.3  (10) 0 0 
  
Tumor volume was measured using the formula v = 4/3 pi 
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 where D1, D2 and D3 are the 
three diameters (mm) of the tumor. Tumor burden was calculated by multiplying tumor volume and the number 
of tumors/hamster. ( ) indicated total number of hamsters bearing tumors. Values are given as mean ± SD.  
 
 
 
 
 
 
 
 
Table 2. Effect of Withaferin-A on DMBA induced bone marrow micronuclei formation  
 
 
Parameters 
-----------------------------
Groups 
MnPCEs/2500 PCEs PCEs/NCEs PCEs (%) ╫ 
 
Group 1  
Control 
 
6.04 ± 0.69 a 
 
1.05 ± 0.07 a 
 
51.1 
 
Group 2  
DMBA 
 
30.6 ± 3.8 b 
 
0.72 ± 0.09b 
 
41.6 
 
Group 3  
DMBA + Withaferin-A 
 
7.06 ± 0.98 c 
 
 
0.97 ± 0.08 c 
 
 
48.5 
 
 
Group 4  
Withaferin-A alone 
 
6.29 ± 0.51 a 
 
 
1.06 ± 0.08 a 
 
51.6 
 
 
Values are expressed as mean ± SD (n =10; 2500 PCEs were scored per hamster). 
Values not sharing a common superscript letter differ significantly at P<0.05 (DMRT).      
 
╫Percentage of polychromatic erythrocytes was calculated as follows: [PCEs/(PCEs+NCEs)] X100. 
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Table 3: Activities of detoxication agents in buccal mucosa of control and experimental hamsters in each group 
(n = 10) 
Parameters 
------------------------
Groups 
GSH  
(mg/100 g 
tissue) 
GST (nmol 
CDNB-GSH conjugate 
formed/min/mg/protein) 
GSSG  
(µg/g tissue) 
Group 1  
Control 5.26 ± 0.38 
a
 
 
1.27 ± 0.08 a 
 
 
14.7 ± 1.1 a 
 
 
Group 2  
DMBA 
 
8.85 ± 0.92 b 
 
 
3.08 ± 0.35 b 
 
 
9.1 ± 0.98 b 
 
 
Group 3  
DMBA + Withaferin-A 
 
 
5.87 ± 0.62 c 
 
 
1.47 ± 0.25 c 
 
 
13.5 ± 1.2 c 
 
 
Group 4  
Withaferin-A alone 
 
5.34 ± 0.43 a 
 
 
1.28 ± 0.10 a 
 
15.0 ± 1.3 a 
Values are expressed as mean ± SD for 10 hamsters in each group. 
Values not sharing a common superscript letter differ significantly at P<0.05 (DMRT).    
 
 
 
 
 
 
Discussion 
 
 Chemopreventive agents exert their tumor suppressive effect by preventing metabolic activation of 
carcinogens, stimulating detoxication of the carcinogens, blocking the interaction of ultimate carcinogen with 
cellular macromolecules or by suppressing the clonal expression of the neoplastic cells (Aruna and 
Sivaramakrishnan, 1990). In the present study, we have investigated the modifying effects of Withaferin-A on 
bone marrow micronucleus frequency and buccal mucosa detoxication agents during DMBA-induced hamster 
buccal pouch carcinogenesis. Withaferin-A completely prevented the tumor formation in DMBA painted 
hamsters, which is probably due to its suppressive effect on cell proliferation.  
Genotoxic agents such as carcinogens can enhance the error rate in the genome reduplication and cause 
mutation in the DNA of an organism. DMBA exposure result in a marked increase in tumor burden and tumor 
volume in rodent models and pronounced mutagenic response in several in vivo and in vitro mutation assay 
system (Chang et al., 1996). DMBA on metabolic activation produces dihydrodiol-epoxides, which mediate 
neoplastic transformation by causing chromosomal abnormalities and mutations in key growth regulatory genes 
(Miyata et al., 2001; Hodgson, 2000; Senthil et al., 2007). DMBA can oxidize both DNA bases and deoxyribose 
sugar through its active metobolite diol epoxides (Miyata et al., 2001). N-ras mutation, Ha-ras mutation and A-T 
transversion in H-ras codon 61 were demonstrated in DMBA induced experimental oral carcinogenesis (Osaka et 
al., 1996; Chang et al., 1996). Several studies have also documented increased MnPCEs frequency during 
DMBA-induced hamster buccal pouch carcinogenesis (Bhuvanesvari et al., 2005; Chandramohan et al., 2006). 
Our results lend credence to these observations. Oral administration of Withaferin-A to DMBA painted hamsters 
significantly reduced the frequency of MnPCEs. Some studies have demonstrated that Withaferin-A has potent 
anti-inflammatory, antioxidant and antitumor properties (Yang et al., 2007; Bargagna-Mohan et al., 2007; 
Bhattacharya et al., 1997). Our results indicate that Withaferin-A might have protected DNA damage by 
inhibiting the metabolic activation of DMBA. 
 Phase II detoxication agents play a vital role in detoxication of pro- and ultimate carcinogens and 
thereby reducing DNA damage (Senthil et al., 2007). Altered activities of liver and buccal mucosa phase II 
detoxication agents are well documented in experimental oral carcinogenesis (Schwartz and Shklar, 1996; 
Chandramohan et al., 2006). Our results corroborate these observations. The status of phase II detoxication agents 
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in the buccal pouch reverted to near normal in DMBA painted hamsters, after treatment with Withaferin-A. Our 
results indicate that Withaferin-A probably modulated the activities of phase II detoxication agents to prevent the 
mutagenic and carcinogenic effect of the carcinogen, DMBA. 
 
Conclusion    
 
 Our study thus demonstrates the protective effect of Withaferin-A on DMBA-induced micronucleus 
frequency in the bone marrow of golden Syrian hamsters. Also, Withaferin-A maintained the status of buccal 
mucosa detoxication agents during DMBA induced hamster buccal pouch carcinogenesis.  
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